Teresa Battista
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Guselkumab In A Subset Of Multifailure Patients With Hidradenitis Suppurativa: Real-Word Evidence from Federico II.
Journal: Clinical, cosmetic and investigational dermatology
Published: June 02, 2025
An Unusual Case of Fibromatous Fibrosis in a Young Hidradenitis Suppurativa Patient.
Journal: Case reports in dermatology
Published: March 21, 2025
Severe Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa Patient.
Journal: Dermatology and therapy
Published: January 19, 2025
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature.
Journal: Clinical, cosmetic and investigational dermatology
Published: December 15, 2024
Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging Association.
Journal: Clinical, cosmetic and investigational dermatology
Published: November 06, 2024
Reply to 'Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa' by Holgersen et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 26, 2024
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review.
Journal: Viruses
Published: October 14, 2024
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study.
Journal: Clinical and experimental dermatology
Published: September 11, 2024
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes-A Review of the Literature.
Journal: Medicina (Kaunas, Lithuania)
Published: August 21, 2024
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis.
Journal: Expert opinion on drug safety
Published: August 12, 2024
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration - A Case Report.
Journal: Clinical, cosmetic and investigational dermatology
Published: April 05, 2024
Management of Psoriasis Patients with Serious Infectious Diseases.
Journal: Advances in therapy
Published: March 12, 2024
Last Updated: 09/26/2026